PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
PhAST Diagnostics has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
PhAST Diagnostics's investors include Massachusetts Life Sciences Center.
PhAST Diagnostics is headquartered in Cambridge, United States.
PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
PhAST Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhAST Diagnostics — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/phast-diagnostics. Accessed July 21, 2026.
VCBacked. (2025). PhAST Diagnostics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/phast-diagnostics
{{cite web |title=PhAST Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/phast-diagnostics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated